Literature DB >> 28258419

Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?

David M Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28258419     DOI： 10.1007/s40263-017-0411-6

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  26 in total

1.  The Role of Clozapine in Treatment-Resistant Schizophrenia.

Authors:  John M Kane; Christoph U Correll
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

2.  Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.

Authors:  Jeffrey A Lieberman; Michael Phillips; Hongbin Gu; Scott Stroup; Peiyan Zhang; Lan Kong; Zhongfu Ji; Gary Koch; Robert M Hamer
Journal:  Neuropsychopharmacology       Date:  2003-03-26       Impact factor: 7.853

3.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

4.  Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial.

Authors:  Ragy R Girgis; Michael R Phillips; Xiaodong Li; Kejin Li; Huiping Jiang; Chengjing Wu; Naihua Duan; Yajuan Niu; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2011-10       Impact factor: 9.319

5.  Savings in hospital bed-days related to treatment with clozapine.

Authors:  W H Reid; M Mason; M Toprac
Journal:  Hosp Community Psychiatry       Date:  1994-03

Review 6.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Toshiaki A Furukawa; Georgia Salanti; John R Geddes; Julian Pt Higgins; Rachel Churchill; Norio Watanabe; Atsuo Nakagawa; Ichiro M Omori; Hugh McGuire; Michele Tansella; Corrado Barbui
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

Review 7.  Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.

Authors:  A Sparshatt; D Taylor; M X Patel; S Kapur
Journal:  Acta Psychiatr Scand       Date:  2009-07-01       Impact factor: 6.392

8.  Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.

Authors:  S Ulrich; B Baumann; R Wolf; D Lehmann; B Peters; B Bogerts; F P Meyer
Journal:  Int J Clin Pharmacol Ther       Date:  2003-01       Impact factor: 1.366

9.  18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital.

Authors:  W H Wilson; A M Claussen
Journal:  Psychiatr Serv       Date:  1995-04       Impact factor: 3.084

Review 10.  Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Corrado Barbui; Georgia Salanti; Jennifer Rendell; Rachel Brown; Sarah Stockton; Marianna Purgato; Loukia M Spineli; Guy M Goodwin; John R Geddes
Journal:  Lancet       Date:  2011-08-16       Impact factor: 79.321
View more
  12 in total

Review 1.  Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.

Authors:  Masataka Wada; Yoshihiro Noda; Yusuke Iwata; Sakiko Tsugawa; Kazunari Yoshida; Hideaki Tani; Yoji Hirano; Shinsuke Koike; Daiki Sasabayashi; Haruyuki Katayama; Eric Plitman; Kazutaka Ohi; Fumihiko Ueno; Fernando Caravaggio; Teruki Koizumi; Philip Gerretsen; Takefumi Suzuki; Hiroyuki Uchida; Daniel J Müller; Masaru Mimura; Gary Remington; Anthony A Grace; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2022-04-20       Impact factor: 15.992

2.  Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie.

Authors:  Anaïs Vandevelde; Lucie Métivier; Sonia Dollfus
Journal:  Can J Psychiatry       Date:  2020-11-02       Impact factor: 4.356

3.  Achieving stable remission with maintenance electroconvulsive therapy in a patient with treatment-resistant schizophrenia: A case report.

Authors:  Sebastian Moeller; Neele Kalkwarf; Caroline Lücke; Diana Ortiz; Sonja Jahn; Christiane Först; Niclas Braun; Alexandra Philipsen; Helge H O Müller
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.

Authors:  Susanna Every-Palmer; Pete M Ellis
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

5.  Impact of Pharmacist Counselling on Clozapine Knowledge.

Authors:  Ciara Ní Dhubhlaing; Ailish Young; Laura J Sahm
Journal:  Schizophr Res Treatment       Date:  2017-06-13

6.  Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells.

Authors:  Vijayasree V Giridharan; Giselli Scaini; Gabriela D Colpo; Tejaswini Doifode; Omar F Pinjari; Antônio L Teixeira; Fabricia Petronilho; Danielle Macêdo; João Quevedo; Tatiana Barichello
Journal:  Cells       Date:  2020-02-28       Impact factor: 6.600

Review 7.  Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety-Particularities in the Context of COVID-19.

Authors:  Ana Miruna Dragoi; Ioana Radulescu; Bogdana Adriana Năsui; Anca Lucia Pop; Valentin Nicolae Varlas; Simona Trifu
Journal:  Brain Sci       Date:  2020-11-11

8.  Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies.

Authors:  S E Smart; A P Kępińska; R M Murray; J H MacCabe
Journal:  Psychol Med       Date:  2019-08-29       Impact factor: 7.723

Review 9.  A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.

Authors:  Jose de Leon; Can-Jun Ruan; Georgios Schoretsanitis; Carlos De Las Cuevas
Journal:  Psychother Psychosom       Date:  2020-04-14       Impact factor: 17.659

Review 10.  Binding of clozapine to the GABAB receptor: clinical and structural insights.

Authors:  Pramod C Nair; Ross A McKinnon; John O Miners; Tarun Bastiampillai
Journal:  Mol Psychiatry       Date:  2020-03-13       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.